Latest Cellcolabs News & Updates

See the latest news and media coverage for Cellcolabs. We track all announcements, press releases, and industry mentions in real time, all in one place.

Cellcolabs

GMP mesenchymal stem cell manufacturer

cellcolabs.com

Headquarters: Solna, Sweden
Founded year: 2021
Company type: Private company
Number of employees: 70–200

Last updated Today

Latest news about Cellcolabs

In short: Cellcolabs appointed Vincent Metzler as CEO, secured $12 million in funding, and expanded its focus on B2B partnerships and clinical trials.

Company announcements

June 22 Cellcolabs

Cellcolabs treats first patient in Phase 2 knee osteoarthritis study

The Phase 2 study evaluates MSC therapy for pain and knee structure, building on promising earlier results at Burjeel Medical City in Abu Dhabi.

May 28 Cellcolabs

Cellcolabs appoints Vincent Metzler as CEO

The appointment marks a new growth phase focused on strategic collaborations and scaling stem cell platform.

February 27 Cellcolabs

Cellcolabs formalizes collaboration with CUHK center

They signed an MoU for a Phase I/II trial on knee osteoarthritis, providing GMP-certified mesenchymal stem cells. They anticipate advancing the work together.

February 10 Cellcolabs

Cellcolabs strengthens commercial focus

The company prioritizes B2B partnerships, orthopedics and knee osteoarthritis as well as recruits new CEO and CMO. Revenues increased 40% to 57 MSEK 2025.

Media coverage

January 23 Dagens industri

Cellcolabs CEO resigns with immediate effect

The stem cell company Cellcolabs, known for being backed by several heavy tech profiles and for its clinical studies on a remote paradise island. Now it changes...

27 October 2025 MSN

Abu Dhabi-based Titian acquires stake in Swedish biotech firm

Abu Dhabi-headquartered Titian Capital, through one of its group companies, has acquired a "significant interest" in Swedish biotechnology company Cellcolabs AB. The investment will be...

7 August 2025 TNW

Stem cell startup proclaims ‘inflection point’ for medicine as mass production nears

It’s harvest day at the Karolinska Institute in Stockholm. As sunshine bathes the leafy university campus, scientists inside the labs work under cool fluorescent light...

5 March 2024 Tech.eu

Swedish biotech Cellcolabs secures $8.7M for affordable stem cell production

Clinical-stage biotech company Cellcolabs today announced that it has raised $8.7 million, bringing its funding to $21.5 million. Cellcolabs is a Swedish biotech company that...

Never miss news about Cellcolabs

Track Cellcolabs and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.